loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2004_254___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    MERCK & CIE

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 MERCK & CIE KMG Schaffhausen CH (1)

    filter

    01 Mesalazine, Micronised (1)

    filter

    01 Switzerland (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    MERCK & CIE KMG Schaffhausen CH

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Mesalazine, Micronised

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2004-254 - Rev 01
    Withdrawn by Holder
    Chemical
    2013-01-31
    2015-09-29
    1699
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2004-254 - Rev 01 of Merck & Cie Kmg Schaffhausen Ch

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2004-254 - Rev 01 of Merck & Cie Kmg Schaffhausen Ch 1

    20

    Merck & Cie Kmg Schaffhausen Ch, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their significant offerings is Mesalazine, Micronised, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2004-254 - Rev 01

    This Chemical Type CEP, issued on January 31, 2013, remains in force until September 29, 2015, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1699 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY